Remote Oncology Portfolio Strategy Director

Ladders; United States; Remote; USD 190,000 - 237,000; Full time

Benefits offered by this job

Comprehensive health benefits

Retirement savings plan

Professional development opportunities

Flexible work arrangements

Collaborative work environment

Job summary

Ladders is seeking a Director, Portfolio Strategy to shape oncology portfolio direction by translating market and disease-area insights into actionable strategy. The role partners with executive stakeholders to inform new indication opportunities and support high-impact decision-making.

Focus is on solid tumor oncology, building integrated strategic frameworks and market research inputs that guide portfolio planning. Location is remote with global reach and competitive compensation.

Qualifications

• Experience in pharmaceuticals/biotech with a focus on oncology.
• Strong understanding of the solid tumor oncology landscape and portfolio strategy.
• Proven ability to conduct qualitative and quantitative market research.

Responsibilities

• Lead strategy and planning for new oncology indications
• Develop the framework for overall portfolio strategy and support strategic decision-making
• Deliver market and competitive intelligence insights for executive decision-making
• Create an integrated disease area strategy for new solid tumor indications
• Partner with the business development team on business development and collaboration opportunities
• Conduct deep analysis of competitors and market trends
• Execute comprehensive market research plans and ensure timely deliverables

Skills

Strategic thinking

Market research

Communication skills

Presentation skills

Travel

Education

Bachelor's degree in biotech or related field

MS or PhD preferred

Job description

Ladders is seeking a Director, Portfolio Strategy to shape oncology portfolio direction by translating market and disease-area insights into actionable strategy. The role partners with executive stakeholders to inform new indication opportunities and support high-impact decision-making.

Focus is on solid tumor oncology, building integrated strategic frameworks and market research inputs that guide portfolio planning. Location is remote with global reach and competitive compensation.